Skip to content

Total Equity at other companies

Emergent Biosolutions logo
Emergent BiosolutionsEBS
$523.1M-5.4%
Opko Health logo
Opko HealthOPK
$1.2B-8.2%
Merck & Co. logo
Merck & Co.MRK
$45.88B-5.1%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
$394.88M+12.8%
Septerna, Inc. logo
Septerna, Inc.SEPN
$378.46M+195%
Charles River Laboratories logo
Charles River LaboratoriesCRL
$2.94B-7.9%

Other financials

Income statement

See full
Revenue$6.2M-11.3%
Gross profit$3.3M-52.0%
Operating income-$5.3M-136%
Net income-$3.5M-746%
EPS (diluted)-$0.05-400%

Balance sheet

See full
Cash & equivalents$145.6M-10.3%
Total debt$601.0K-50.6%
Total assets$219.4M-11.2%

Cash flow

See full
Operating cash flow-$8.7M-223%
CapEx--100%
Free cash flow-$8.7M-223%

Valuation

See full
Market cap$261.08M-44.3%
Enterprise value$116.11M-59.6%
P/E10.3×+3.8×
P/S2.8×+0.2×

Profitability

See full
Gross margin65.4%-11.2pp
Operating margin52.4%-7.8pp
Net margin43.2%-6.1pp
FCF margin66.2%

Returns & leverage

See full
Return on equity39.9%-18.5pp
Debt / equity0.0×
Current ratio3.2×-5.2×

Where this comes from

Reported directly by SIGA Technologies in its filing.

Tagged under the XBRL concept us-gaap:StockholdersEquity.

The official record: SIGA Technologies’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about SIGA Technologies's total equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SIGA Technologies's total equity?
SIGA Technologies (SIGA) reported total equity of $151.62M in Q1 2026.
How has SIGA Technologies's total equity changed year-over-year?
SIGA Technologies's total equity decreased by 29.8% year-over-year, from $216.13M to $151.62M.
What is the long-term trend for SIGA Technologies's total equity?
Over 5 years (2020 to 2025), SIGA Technologies's total equity has grown at a 8.9% compound annual growth rate (CAGR), from $129.79M to $198.82M.
What does total equity mean?
Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.